Lucerno Dynamics
Lucerno Dynamics has developed a breakthrough system that can detect and quantify the dynamic uptake of radiolabeled biomarkers in tissue quickly, safely, and inexpensively. Any therapeutic or diagnostic procedure that can use a radiolabeled biomarker is a candidate to use Lucerno technology to help quantify and visualize the result in the target tissue. Identified uses include oncology, Alzheimer’s, kidney function, auto-immune, and more.
Year Invested 2015
Investment Status Active
Theme Decisions
Website www.lucerno.com